2007
DOI: 10.1182/blood-2005-05-022004
|View full text |Cite
|
Sign up to set email alerts
|

Growth factor independence-1 (Gfi-1) plays a role in mediating specific granule deficiency (SGD) in a patient lacking a gene-inactivating mutation in the C/EBPϵ gene

Abstract: Neutrophil-specific granule deficiency (SGD) is a rare congenital disorder marked by recurrent bacterial infections. Neutrophils from SGD patients lack secondary and tertiary granules and their content proteins and lack normal neutrophil functions. Gene-inactivating mutations in the C/EBPepsilon gene have been identified in 2 SGD patients. Our studies on a third SGD patient revealed a heterozygous mutation in the C/EBPepsilon gene. However, we demonstrate elevated levels of C/EBPepsilon and PU.1 proteins in th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
59
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 52 publications
(63 citation statements)
references
References 42 publications
4
59
0
Order By: Relevance
“…45,46 In addition, diminished Gfi1 expression may contribute to the development of neutrophil-specific granule deficiency by causing reduced levels of secondary granule protein expression. 32 A condition similar to human SCN is encountered in mice that lack Gfi1 or that express the mutated form of Gfi1 found in a SCN patient. [47][48][49] This strongly suggests that the mutated Gfi1 form that causes SCN, functions in a dominant-negative manner over wild-type Gfi1.…”
Section: Biological Roles Of Gfi1 and Gfi1bmentioning
confidence: 99%
See 2 more Smart Citations
“…45,46 In addition, diminished Gfi1 expression may contribute to the development of neutrophil-specific granule deficiency by causing reduced levels of secondary granule protein expression. 32 A condition similar to human SCN is encountered in mice that lack Gfi1 or that express the mutated form of Gfi1 found in a SCN patient. [47][48][49] This strongly suggests that the mutated Gfi1 form that causes SCN, functions in a dominant-negative manner over wild-type Gfi1.…”
Section: Biological Roles Of Gfi1 and Gfi1bmentioning
confidence: 99%
“…5,15,26,27,[29][30][31] However, it should be noted that examples have been reported in which Gfi1 and Gfi1b can activate gene expression. 15,18,29,32 Gfi1 and Gfi1b also interact physically with other transcription factors through their zinc fingers to co-regulate gene expression (Figures 1 and 2). 17,29,[33][34][35][36] For example, Gfi1 interacts directly with ETS1 to repress the Bax gene through adjacent DNA binding sites.…”
Section: Structure and Expression Regulation Of Gfi1 And Gfi1b Proteinsmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been shown previously that there is no change in the ability of Sp1 to bind DNA during the course of G-CSF induced differentiation of 32Dcl3 cells (Nuchprayoon et al, 1999), so Sp1 may depend on posttranslational modification or binding to inducible partners to preferentially activate transcription of target genes in response to a stimulus such as G-CSF. The promoters of CD11b (Chen et al, 1993), CD11c (Noti et al, 1996), CD14 (Zhang et al, 1994), CD18 (Rosmarin et al, 1998), as well as c-fes (Heydemann et al, 1996), myeloperoxidase (Piedrafita et al, 1996), lactoferrin (Khanna-Gupta et al, 2000), neutrophil elastase (Nuchprayoon et al, 1999), myeloid cell nuclear differentiation antigen (Kao et al, 1997), and human hematopoietic cell kinase (Hauses et al, 1998) all are preferentially activated in myeloid cells through mechanisms involving Sp1. If there is a requirement of an inducible partner for Sp1 to direct myeloid-specific transcription, then Stat3 may play that role.…”
Section: Discussionmentioning
confidence: 99%
“…Transient transfection of 32Dcl3 cells was achieved by electroporation, as described previously (Khanna-Gupta et al, 2000). Following electroporation, cells were left unstimulated or stimulated with 100 ng/ml of recombinant murine G-CSF (Stem Cell Technologies, Vancouver, BC, Canada).…”
Section: Plasmid Constructionmentioning
confidence: 99%